title: Are synthetic peptides sensitive enough for screening anti-hepatitis C virus at blood banks?
authors.forename: P
authors.initials: P
authors.lastname: León
authors.forename: J A
authors.initials: JA
authors.lastname: López
authors.forename: C
authors.initials: C
authors.lastname: Elola
authors.forename: C J
authors.initials: CJ
authors.lastname: Domingo
authors.forename: J M
authors.initials: JM
authors.lastname: Echevarría
mesh_terms: D000956:Antigens, Viral / Q000276:immunology*; D001771:Blood Banks; D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control; D018937:Hepatitis C Antibodies; D006801:Humans; D007124:Immunoenzyme Techniques; D008403:Mass Screening / Q000379:methods*; D010446:Peptide Fragments / Q000276:immunology*; D012680:Sensitivity and Specificity
chemical_list: D000956:Antigens, Viral; D006508:Hepatitis Antibodies; D018937:Hepatitis C Antibodies; D010446:Peptide Fragments